Showing results (191-200 of 322) with videos related to
Sort By:
Pageof 33
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Effective in vivo induction of lymphokine-activated killer (LAK) cells by pretreatment with a streptococcal preparation, OK-432K Shimoda, T Saito, M Kobayashi, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1992
A comparative study on immunosuppressive effects of cyclosporin A and FK 506 on peripheral blood lymphocytes in dogsK Takaori, Y Nio, K Inoue, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Cytokines and the host defense against Listeria monocytogenes and Salmonella typhimuriumI A Langermans, R van FurthBiotherapy (Dordrecht, Netherlands)|January 1, 1994
The role of cytokines in mycobacterial infectionJ H Champsi, L E Bermudez, L S YoungBiotherapy (Dordrecht, Netherlands)|January 1, 1993
Long-term follow up of patients with common variable immunodeficiency treated with intravenous immunoglobulin: reevaluation of intravenous immunoglobulin replacement therapy. IVIG therapy in CVIDK Mushiake, F Motoyoshi, N Kondo, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Enhancement of interferon-beta production with sphingomyelin from fermented milkK Osada, K Nagira, K Teruya, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Suppression of cytokine production by supernatants from CD8+ lymphocytes activated by mycobacterial fractions: the role of interleukins 4 and 6A A Wadee, G Sussman, R H Kuschke, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
A recombinant human interleukin-1 beta protects adriamycin-induced toxicity. Adriamycin cardiotoxicity and interleukin-1H Okumura, T Yoshida, H Kaya, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1991
Inhibition of growth of rat hepatoma by local injection of liposomes containing recombinant interleukin-2. Antitumor effect of IL-2 liposomeH Konno, A Yamashita, T Tadakuma, et al.Pageof 33